PabloCOkhuysenMD

HIV/AIDS Medicine, Transplant/Immunocompromised States, International Health, Travel & Tropical

Professor, Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX

Dr. Okhuysen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
The University of Texas MD Anderson Cancer Center
1515 Holcombe, Unit 1460
Houston, TX 77030
Phone+1 713-745-8413

Fax+1 713-745-6839

University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1991 - 1994
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1989 - 1991
Cook County Health and Hospitals SystemInternship, Internal Medicine, 1988 - 1989
Universidad de GuadalajaraClass of 1988

PubMed

2852 citations
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews
Science. 2018-01-05
80 citations
Traveler's diarrhea due to intestinal protozoa
Pablo C. Okhuysen
Clinical Infectious Diseases. 2001-07-01
22 citations
Enteroaggregative E. coli Adherence to Human Heparan Sulfate Proteoglycans Drives Segment and Host Specific Responses to Infection
Anubama Rajan, Matthew J. Robertson, Hannah E. Carter, Nina M. Poole, Justin R. Clark
Plos Pathogens. 2020-09-28

Jaguar Health's Stock Slides 68% After Cancer Trial Fails to Meet Main GoalJuly 23rd, 2024
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis ProductMay 23rd, 2024
Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Crofelemer (Mytesi) for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer TherapyOctober 7th, 2020
Join now to see all

Gene Polymorphisms Predisposing To Infectious DiarrheaNational Institute Of Allergy And Infectious Diseases2003–2007
IL-2 (PROLEUKIN) In HIV+ Patients In A Randomized International Trial (ESPRIT)National Center For Research Resources2005
Comparison Of The Clinical Consequences Of Two Anti-Retroviral Regimens In HIVNational Center For Research Resources2005
Ucrc Special Case Study ProtocolNational Center For Research Resources2004–2005
Infectivity Of Cryptosporidium Parvum For Adult HumansNational Center For Research Resources1998–2005
IL-2 (PROLEUKIN) In HIV+ Patients In A Randomized TrialNational Center For Research Resources2004
Infectivity Of Cryptosporidium Parvumfor Adult HumansNational Center For Research Resources1999–2002
Arginine Aminopeptidases Of Cryptosporidium ParvumNational Center For Research Resources1996–1999